We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$492B
AUM Growth
+$21.5B
Cap. Flow
-$6.18B
Cap. Flow %
-1.26%
Top 10 Hldgs %
30.05%
Holding
13,811
New
1,371
Increased
4,862
Reduced
5,559
Closed
1,866

Sector Composition

Rank Sector Weight
1 Technology 2.7%
2 Consumer Discretionary 1.66%
3 Financials 1.18%
4 Communication Services 1.07%
5 Healthcare 0.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRMA icon
11576
Dermata Therapeutics
DRMA
$7.98M
$20.9K ﹤0.01%
+84
New +$22.9K
QCLS
11577
CALL
Q/C Technologies Inc
QCLS
$20.4M
$20.6K ﹤0.01%
+5
New +$26.1K
ASXC
11578
PUT
DELISTED
Asensus Surgical, Inc.
ASXC
$20.5K ﹤0.01%
40,100
-200
-0.5% -$120
ZFOX
11579
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
$20.4K ﹤0.01%
+20,416
New +$22.6K
UP icon
11580
PUT
Wheels Up
UP
$184M
$20.4K ﹤0.01%
870
+796
+1,076% +$56.3K
TLPH icon
11581
CALL
Talphera
TLPH
$65.4M
$20.3K ﹤0.01%
18,300
-10,100
-36% -$8.82K
OPTT icon
11582
CALL
Ocean Power Technologies
OPTT
$49M
$20.1K ﹤0.01%
33,500
TCRT icon
11583
CALL
Alaunos Therapeutics
TCRT
$4.52M
$20K ﹤0.01%
262
+21
+9% +$1.7K
ITP icon
11584
IT Tech Packaging
ITP
$3.06M
$19.9K ﹤0.01%
42,420
+15,858
+60% +$7.27K
VANI icon
11585
Vivani Medical
VANI
$128M
$19.9K ﹤0.01%
16,476
-78,746
-83% -$97K
CTHR
11586
DELISTED
Charles & Colvard Ltd
CTHR
$19.9K ﹤0.01%
2,082
+864
+71% +$8.57K
IDEX
11587
PUT
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$19.9K ﹤0.01%
2,272
-1,484
-40% -$11.4K
QNRX
11588
Quoin Pharmaceuticals
QNRX
$10.4M
$19.7K ﹤0.01%
+95
New +$19.6K
RDHL
11589
CALL
Redhill Biopharma
RDHL
$3.74M
$19.5K ﹤0.01%
644
-16
-2% -$922
CCO icon
11590
PUT
Clear Channel Outdoor Holdings
CCO
$1.22B
$19.5K ﹤0.01%
+14,200
New +$17.7K
XXII
11591
CALL
22nd Century Group
XXII
$2.42M
0
GYRE icon
11592
Gyre Therapeutics
GYRE
$705M
$19.4K ﹤0.01%
3,670
-213
-5% -$764
BKYI
11593
BIO-key International
BKYI
$4.25M
$19.2K ﹤0.01%
139
+32
+30% +$4.26K
BSQR
11594
CALL
DELISTED
BSQUARE Corporation
BSQR
$19.2K ﹤0.01%
14,800
-10,100
-41% -$11.9K
CODX
11595
PUT
Co-Diagnostics
CODX
$8.73M
$19.2K ﹤0.01%
577
+87
+18% +$3.33K
CPTN
11596
DELISTED
Cepton, Inc. Common Stock
CPTN
$19.1K ﹤0.01%
3,943
+1,910
+94% +$8.38K
SUNW
11597
DELISTED
Sunworks, Inc.
SUNW
$19.1K ﹤0.01%
16,922
-8,243
-33% -$9.21K
OPTT icon
11598
Ocean Power Technologies
OPTT
$49M
$18.9K ﹤0.01%
31,522
-33,271
-51% -$18.2K
KRON
11599
DELISTED
Kronos Bio
KRON
$18.9K ﹤0.01%
10,968
-115,815
-91% -$184K
BSQR
11600
DELISTED
BSQUARE Corporation
BSQR
$18.6K ﹤0.01%
14,339
-61,894
-81% -$72.7K

Similar funds

Jeff Yass's Q2 2023 Portfolio in Review

As of Q2 2023, Jeff Yass held 13,811 positions worth $492B, up 4.6% from $470B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2023 filing shows 1,371 new, 4,862 increased, 5,559 reduced and 1,866 closed positions. Its largest new stake was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M. The largest sale was Invesco QQQ Trust, an estimated $2.48B.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, up from 2.3% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Jeff Yass's largest Q2 2023 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M.
  • Jeff Yass added most to NVIDIA in Q2 2023, an estimated $1.79B increase.
  • Jeff Yass's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $2.48B.
  • Jeff Yass fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2023, selling an estimated $45.5M.
  • Jeff Yass's ten largest holdings make up 30% of its $492B portfolio in Q2 2023.
  • Jeff Yass opened 1,371 new positions and closed 1,866 in Q2 2023.
  • Jeff Yass's portfolio value rose 4.6% quarter-over-quarter to $492B.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.